Flavoxate Hydrochloride

CHEMBL1200875 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

427.9 g/mol

LogP

—

Phase

4

This hydrochloride salt form of flavoxate is used to relieve discomfort associated with urinary tract conditions, including frequent urination and bladder spasms. It relaxes bladder smooth muscle through multiple mechanisms to reduce urinary symptoms.

Moleküler Ağırlık

427,9000 g/mol

TPSA

55,80 Å²

Terapötik Alanlar

Pain Management Chronic Pain

Etki Mekanizması

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O.Cl

InChI

InChI=1S/C24H25NO4.ClH/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25;/h2,4-5,8-12H,3,6-7,13-16H2,1H3;1H

Molecular Formula

C24H26ClNO4

HBD / HBA

1 / 5

Döndürülebilir Bağlar

6

Ağır Atomlar

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This hydrochloride salt form of flavoxate is used to relieve discomfort associated with urinary tract conditions, including frequent urination and bladder spasms. It relaxes bladder smooth muscle through multiple mechanisms to reduce urinary symptoms.

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Yes, Flavoxate Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200875. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 441345. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Flavoxate Hydrochloride PillFYI'da

Yapı

Hızlı Veriler

Formül: C24H26ClNO4

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.

Flavoxate Hydrochloride

Terapötik Alanlar

Etki Mekanizması

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

Cite this structure

Embed this structure

No targets recorded

No interactions recorded

No side effects recorded

Sıkça Sorulan Sorular

References & Data Sources

Embed This Widget